January/February 2020 Newsletter
|
|
In this issue:
- President's Message from Alex Oschman
- Board Update
- Research & Education Foundation Update
- Public Policy Update
- Pharmacist Continuing Education Opportunities
- Optimizing the Initiation of Anticoagulation after Atrial Fibrillation Associated Ischemic Stroke
- Vancomycin dosing: Area Under the Curve Versus Trough
- Featured Clinical Topic – Endocrinology
- SGLT2 Inhibitors and Renal Outcomes
- Perioperative Glycemic Management Throughout the Surgical Continuum of Care
- The First Oral Glucagon-like Peptide-1 Receptor Agonist - Rybelsus®
- Assessing Care Plans for Patients with Type 2 Diabetes Practicing Religious and Cultural Fasting
- 2020 Spring Meeting
- Registration
- Affiliate Chapter News and Events
- Upcoming Newsletter Info
|
|
President's Message
from Alex Oschman
|
|
"You do not like them, so you say. Try them! Try them! And you may!"
– Dr. Seuss
As the new year starts, many of us are setting new goals for the year, both personal and professional. An article recently reported that January 19th is the day most people are likely to give up on their New Year’s Resolutions. While there are lots of ways to build new habits and implement changes, one way to help be successful in your goals is to engineer your environment to set you up for success.
|
|
|
|
Author: Davina Dell-Steinbeck, PharmD, BCPS
MSHP President Elect/SSM Health St. Mary's Hospital
November
- Alex Oschman, Davina Dell-Steinbeck, and Jim Andrews attended ASHP Presidential Officers Retreat and got many good idea on strategic planning and advancing advocacy efforts.
- Keynote speaker for KCHP/MSHP Meeting will be Paul Walker, PharmD, FASHP, ASHP Board of Directors.
|
|
December
- We had a very successful and well attended Missouri Reception at the ASHP Midyear Clinical Meeting
- UMKC Clinical Skills Competition team placed in the top 10 at the ASHP Midyear Clinical Meeting
- President-elect and treasurer-elect will be the open positions on the board election ballot. Submissions portal for nominations will be open soon.
|
|
Research & Education
Foundation Update
|
|
Author: Becca Nolen, Pharm.D., BCPS, BCIDP, AAHIVP Member, MSHP Research and Education Foundation
The local ASHP Clinical Skills Competition winners from both the St. Louis College of Pharmacy and the University of Missouri-Kansas City were recognized during the MSHP reception at Midyear. Congratulations to William Miller & Blake Robbins from STLCOP and Amelia Gooch & Garrett Matthews from UMKC! Thank you for representing Missouri!
|
|
Advocacy: Leadership In Action for Pharmacists and Technicians
Author: Nathan Hanson, PharmD, MS, BCPS
Legislative Day is April 1st - will you be joining us? No, this isn’t a practical joke…advocacy is our job! Why? Because advocacy is leadership in action.
The playoffs are here, and what a year it’s been already! And like most years, this year we have been reminded how important the rules are. We see games decided and seasons completely changed because of one rule and one referee’s interpretation...
|
|
Pharmacist Continuing Education
|
|
Optimizing the Initiation of Anticoagulation after Atrial Fibrillation Associated Ischemic Stroke
Author: Emily Shor, Pharm.D.
Program Number:
2019-12-02
Approval Dates:
January 1, 2020 – June 1, 2020
Approved Contact Hours:
One (1) CE(s) per LIVE session
|
|
Vancomycin dosing: Area Under the Curve Versus Trough
Author: Miriam Chikodili Oguejiofor, Pharm.D
|
Program Number:
2019-12-01
Approval Dates:
January 1, 2020 – June 1, 2020
Approved Contact Hours:
One (1) CE(s) per LIVE session
|
|
Featured Clinical Topic:
Endocrinology
|
|
SGLT2 Inhibitors and Renal Outcomes
Authors: Kathryn M. Holt, PharmD, BCPS, University of Missouri-Kansas City School of Pharmacy, Clinical Assistant Professor Meritas Health North Kansas City;
Amanda M. Stahnke, PharmD, BCACP, University of Missouri-Kansas City School of Pharmacy, Clinical Associate Professor Kansas City VA Honor Annex
|
Diabetes mellitus remains one of the leading causes of chronic kidney disease (CKD) and occurs in 20-40% of people with diabetes.1 With the continued increase in prevalence of CKD in diabetes, limited pharmacologic therapies exist to assist in decreasing the development and progression outside of renin-angiotensin-aldosterone system (RAAS) agents.1-2 Recent clinical trials with sodium-glucose cotransporter 2 inhibitors (SGLT2-Is) have demonstrated their potential role in this much needed area.
|
|
Perioperative Glycemic Management Throughout the Surgical Continuum of Care
Author: Diari Gilliam, PharmD Candidate 2020-Xavier University of Louisiana and Rachel Wolfe, PharmD, BCCCP, Clinical Pharmacist-Barnes-Jewish Hospital
|
|
Diabetes is a metabolic disorder characterized by hyperglycemia due to impaired insulin secretion, insulin action, or a combination of both.1 In the United States, it is a frequently encountered disease state with an estimated incidence of 30.3 million in 2015.
2
While it is well known that chronic hyperglycemia is associated with poor long term outcomes, such as retinopathy, nephropathy, and neuropathy, acute hyperglycemia in the surgical setting has also been associated with poor outcomes.
|
|
The First Oral Glucagon-like Peptide-1 Receptor Agonist - Rybelsus
®
Author: Angelou Song, PharmD Candidate 2021-UMKC School of Pharmacy
Mentor: Barb Kasper, PharmD, BCACP; Clinical Assistant Professor-UMKC School of Pharmacy
|
|
The U.S. Food and Drug Administration (FDA) approved oral semaglutide tablets (Rybelsus
®
) in September 2019.
1
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist analog and the first oral agent developed in the drug class. Oral semaglutide is indicated to lower A1C in patients with Type II Diabetes (T2DM). According to the American Diabetes Association’s recommendations for pharmacological therapy, GLP-1 receptor agonists are used when A1c levels are over 1.5% above the glycemic target, as one of the agents for dual combination therapy.
|
|
Assessing Care Plans For Patients with Type 2 Diabetes Practicing Religious and Cultural Fasting
Author: Lourdes M. Vega, PharmD; St. Louis College of Pharmacy/Department of Public Health PGY1 Pharmacy Resident
Mentor: Justinne Guyton, PharmD, BCACP; St. Louis College of Pharmacy Associate Professor of Pharmacy Practice, PGY1 Pharmacy Residency Program Director
|
|
Fasting practices vary significantly between religious and cultural backgrounds, regions, families, and persons, ranging from giving up a specific food or ingredient to abstaining from food and water entirely. A prolonged fast is defined as abstinence from all food for greater than eight hours while awake. This prolonged fast comes with risk when practiced by patients with type 2 diabetes and is an opportunity for a pharmacist to reevaluate pharmacotherapy selection.
1
|
|
Please submit your nominations for the following awards via the online form by
Saturday, February 15, 2020
. The 2020 Annual Meeting is themed
Past Reflections and Future Visions
. We look forward to seeing you on
April 3 – 4, 2020
at the Sheraton in Overland Park, KS.
- Pharmacist of the year Award
- Outstanding Volunteer Award
- Rising Star Award
- Outstanding Collaborator of the Year Award
|
|
|
|
What:
Educate. Network. Advocate.
The Health-System Pharmacy event of the YEAR
in Kansas and Missouri designed for pharmacists, residents, technicians and students!
When and Where:
The Sheraton
Overland Park, KS
April 3-4, 2020
Theme:
Past Reflections, Future Visions
MSHP will also be celebrating our
50th Year
as an association.
|
|
HELP NEEDED: Do you have pictures from your time in MSHP? Any archives from the past 50 years? We would love to have them for a special 50th Anniversary project! Please email anything you have to
mshp@qabs.com.
|
|
Affiliate Chapter News & Events
|
|
Greater Kansas City Society of Health-System Pharmacists (GKCSHP)
|
|
Upcoming event:
FERAHEME® (ferumoxytol) and new advances in iron replacement therapy
Speaker: Suresh Ratnam, MD, FACP
Location:
The Capital Grille
4760 Broadway Blvd
(816) 531-8345
Thursday, February 20th 2020
Arrival: 6:00PM
Presentation: 6:30PM
GKCSHP is on Instagram! Follow us
@gkcshp!
|
|
Mid-Missouri Society of Health-System Pharmacists (MMSHP)
|
|
Saint Louis Society of Health-System Pharmacists (STLSHP)
Dear STLSHP members,
Please see the details below for our February meeting. We look forward to seeing you there!
Sincerely,
STLSHP Executive Board
Date:
Thursday, February 20
th
Time:
6:30PM
Location:
Bonefish Grill, 8780 Eager Road, Brentwood, MO 63144
Topic:
A Multi-modal Approach to Increase Mean Arterial Pressure in Distributive Shock
Speaker:
Kevin Betthauser, PharmD, BCCCP; Critical Care Clinical Pharmacy Specialist (Medical ICU, Barnes-Jewish Hospital)
Hosted by:
La Jolla Pharmaceutical Company.
Please RSVP to Kelly Gentry at
kgentry@ljpc.com
or call (913)-220-0119 by February 17
th
at 5:00PM.
|
|
Southeast Missouri Society of Health-System Pharmacists (SEMSHP)
|
|
March/April 2020 Newsletter
Featured Clinical Topic:
Psych/Neuro/Pain - FULL
|
|
2020 Featured Clinical Topics
May/June –
Critical Care / Pulm / Emergency Med
- FULL
July/Aug –
Cardiology / Anticoagulation
Sept/Oct –
Pediatrics
Nov/Dec –
ID/Vaccines
|
|
Newsletter Submission Deadlines:
March/April 2020: March 9th
May/June 2020: May 11th
July/August 2020: July 13th
Sept/Oct 2020: September 14th
Nov/Dec 2020: November 9th
|
|
Newsletter Submission Guidelines
- Pharmacists, pharmacy technicians, and pharmacy students in Missouri are eligible to submit content for publication in the MSHP Newsletter. Student submissions need to include pharmacist oversight.
- Submit content to the current Newsletter Committee Chair on or before the established deadlines.
- CE and Featured Clinical Topics must be approved by the Newsletter Committee Chair in advance of article submission, to prevent duplicates. Duplicate articles submitted without advanced approval may not be published.
- Recommended length of submissions for committee, affiliate, college/schools of pharmacy, and student chapter reports is half to one page in length.
- Recommended length of submissions for featured clinical topics is 1 to 2 pages, without references.
- Recommended length of CE articles is individualized, based on the amount of CE provided.
- Recommended length of submission for other categories is 1 to 2 pages.
|
|
Is there a Pharmacy Best Practice happening at your institution? Would you like to share your successes with MSHP Membership? We'd love to highlight your institution in a future MSHP Newsletter!
|
|
Interested in becoming a MSHP member or need to renew? It's easy! Click the above button or visit the MSHP website:
www.moshp.org/join-us.
Membership Dues:
Pharmacist: $110
Joint Pharmacist: (Married Couple) $155
Technician: $35
Associate Member: $110
Recent Graduate (within 24 months): $45
Student: $25
Retired Pharmacist: $35
|
|
2019-2020 Board of Directors
|
|
2019-2020 Committee Chairs
|
|
If you have any questions, comments, or wish to submit an article to for MSHP Newsletter, please contact the Newsletter Committee Chair:
2019-2020 MSHP Newsletter Committee Members
|
|
Connect with Us on Social Media
|
|
We would love for you to connect with us on social media on one of three social media channels!
|
|
|
|
|
|
|
